Objectives: To compare the agreement between microbroth dilution and agar dilution for antimicrobial susceptibility testing of Campylobacter jejuni.
Introduction
Campylobacter jejuni is among the most frequently identified causes of bacterial gastroenteritis in the United States. 1 Throughout many months in any given year, C. jejuni infections have often outnumbered other infectious causes of food-borne illness in the United States, such as Salmonella, Escherichia coli O157:h7 and Shigella, based on CDC reports of annual disease incidence. Based on these data, it has been estimated that up to two million cases of illness may be caused by this organism annually. 2 Most C. jejuni enteritis cases are mild, self-limiting episodes of vomiting, cramping and diarrhoea. However, a more serious form of the illness occurs in infants, geriatric patients and immune suppressed individuals. In these cases, bloody stools, dehydration, septicaemia and long-term sequelae can occur. 3 Secondary effects of C. jejuni gastroenteritis can include the demyelinating neurological disorder of Guillian-Barre syndrome or intermittent arthritis. 4 ,5 C. jejuni can colonize the gastrointestinal tracts of mammals and birds without causing disease. 6, 7 Thus, faecal material from apparently healthy animals may contaminate meat, raw milk or crosscontaminate fresh produce, resulting in human illness. 8, 9 Another primary concern with C. jejuni is that this organism has demonstrated the ability to develop resistance to antimicrobials. 10, 11 Human isolates are displaying increased resistance to many classes of the drugs throughout time and introduction of new pharmaceuticals. 12, 13 This is a global problem. 14 In countries with lax restrictions on human and animal treatment, very high levels of antimicrobial resistance are observed. 15, 16 However, in developed countries, there is ongoing debate regarding the role of antibiotics in animal husbandry and veterinary therapeutics in the food-borne dissemination of bacterial resistance mechanisms. 17, 18 There is documentation of increased fluoroquinolone resistance in C. jejuni and other bacteria once these antimicrobials were approved in some food animal species. 19 In the laboratory setting, C. jejuni is a fastidious organism requiring very specific growth conditions such as a microaerophilic environment and selective media. 20 The NCCLS in the United States has recently standardized agar dilution for antimicrobial testing in this organism. 21, 22 However, many other methods have been employed both for surveillance and in research laboratories including disc diffusion, microbroth dilution and Etest, which has made it difficult to track or compare global trends in C. jejuni resistance. [23] [24] [25] Luber et al. 26 have compared the results of C. jejuni isolates tested by agar dilution, Etest and microbroth dilution. These authors found microbroth dilution performed using the SensiTitre Ò system with commercially prepared antimicrobial reliable, efficient and provided results with a high degree of agreement in classifying the susceptibility of isolates when compared with Etest or agar dilution. However, the C. jejuni used in this German study consisted of isolates from clinical submissions from humans with gastroenteritis and poultry. 26 Agar dilution requires the preparation of serial dilutions of antimicrobials incorporated into a blood agar plate, which is both expensive and time consuming. The prepared plates also have a very short shelf life that therefore requires frequent preparation with ongoing testing such as may occur in longitudinal study designs or clinical laboratory settings. Another consideration is that the NCCLS guidelines for C. jejuni do not incorporate antimicrobials of interest for some research questions. Currently, ciprofloxacin, doxycycline, erythromycin, gentamicin and meropenem are the antimicrobials that are part of the standardized protocol. 21 However, the National Antimicrobial Resistance Monitoring 25 surveillance programme in the United States monitors C. jejuni resistance in humans and animals to azithromycin, chloramphenicol, clindamycin, erythromycin, gentamicin, ciprofloxacin, nalidixic acid and tetracycline using the Etest. In 2000, Wallace and Fedorka-Cray found comparable results between microbroth dilution, Etest and agar dilution for C. jejuni isolates when assessing the antimicrobials of interest for NARMS surveillance.
Therefore, the primary objective of this study was to evaluate the agreement of MICs between automated microbroth dilution using a SensiTitre Ò system and agar dilution for determining antimicrobial susceptibility of C. jejuni isolated from dairy cattle in the United States as part of a large, longitudinal research project that would require efficient processing of thousands of C. jejuni isolates.
Materials and methods
Isolates: cattle samples C. jejuni isolates that had been isolated from dairy cattle were utilized for this study. In order to assess the agreement between ciprofloxacin, erythromycin, nalidixic acid and tetracycline, 172 C. jejuni with diverse MIC outcomes for these four antimicrobials as determined by microbroth dilution technique were used. In order to assess the agreement of ampicillin, 190 isolates with a broad distribution of MICs as determined by microbroth distribution were used. These five antimicrobials were chosen for comparison purposes by the ranges of MICs demonstrated by our isolates, the on-farm exposure to these classes of drugs and/or interest in human C. jejuni resistance surveillance.
Farms were enrolled in the study under confidentiality agreements, and cattle sampling for faecal collection was performed under each respective university animal use guidelines (Michigan State University, Cornell University, University of Wisconsin and University of Minnesota). Cattle samples were collected by placing 10 g of faecal material obtained by rectal retrieval into Whirl-Pak Ò bags. A separate glove was used for the collection of each sample. Animal faecal samples and milk samples were suspended in PBS solution. Although the study design included sampling the farm environment using enrichment, recovery of C. jejuni from farm environments resulted in very few isolates. Therefore, C. jejuni from environmental sources were not included in this study. PBS suspended biological samples were streaked on selective C. jejuni Blaser plates (BD Diagnostics) and incubated at 42 C in microaerophilic conditions (5-10% CO 2 ) in water-jacketed CO 2 incubators (NuAire, Inc., Plymouth, MN, USA, model NU-4500 and VWR, Cornelius, OR, USA, model 2400) for 48 h. Typical colonies were selected and streaked on sheep blood agar (Cleveland Scientific) and incubated at 42 C in microaerophilic conditions (5-10% CO 2 ) for 48 h. C. jejuni identification was performed from isolated colonies by Gram's staining, oxidase testing and motility testing. Hippurate hydrolysis was used to speciate C. jejuni. Over 97% of our isolates were classified as C. jejuni. 27 Taqman PCR was used on a subset of isolates to verify the performance of hippurate testing to adequately identify C. jejuni for 1430 isolates. Among those hippuratepositive isolates tested, 1311 were classified as C. jejuni. Only isolates demonstrating agreement between hippurate hydrolysis and PCR were used in this study.
In vitro susceptibility testing: microbroth dilution
Initial in vitro susceptibility testing was performed using the microbroth dilution method, following guidelines provided by the NCCLS. 21 Bacterial isolates from frozen stock were grown on Brucella agar supplemented with 5% defibrinated sheep blood (BASB) for 48 h at 42 C under microaerophilic conditions (5-10% CO 2 ). Individual colonies from each plate were subcultured on BASB under similar growth conditions. Bacteria were swabbed from the BASB and suspended in 5 mL of H 2 O and the turbidity was adjusted to that of a 0.5 McFarland standard. This suspension was used to make a final bacterial inoculum concentration of 8·10 5 cfu/mL using Haemophilus testing medium (Trek Diagnostics).
Customized microbroth dilution plates (CMV1USDA) were purchased pre-made from TREK Diagnostic Systems, Inc., with a prepared range of drug concentrations of azithromycin, chloramphenicol, ciprofloxacin, clindamycin, erythromycin, gentamicin, nalidixic acid and tetracycline. C. jejuni ATCC 33560 was used as a quality control strain. Each plate was inoculated by adding 100 mL of the bacterial suspension using a SensiTitre Ò autoinoculator, covered with a gaspermeable seal and incubated at 42 C at 5% CO 2 for 48 h. The MIC was determined as the minimum antimicrobial dilution at which no bacterial growth occurred. Following the observation that dairy isolates did not demonstrate resistance patterns similar to those from humans, another customized antimicrobial panel (CMV2DMSU) was developed with Trek Diagnostics to address drug exposures that are common to dairy cattle management. This antimicrobial panel included 17 drugs encompassing drug classes used on our study farms such as b-lactams and cephalosporins. 28 In vitro susceptibility testing: agar dilution Bacterial isolates from frozen stock were grown on Brucella agar supplemented with BASB for 48 h at 42 C under microaerophilic conditions (5-10% CO 2 ). Individual colonies from each plate were subcultured on BASB under similar growth conditions. Agar dilution was performed according to the NCCLS-VAST guidelines. MuellerHinton agar (Michigan State University Media Services) was supplemented with 5% sheep blood (Cleveland Scientific, Cleveland, OH, USA) and each antimicrobial agent according to the concentration ranges in Table 1 in order to compare agreement of the antimicrobial susceptibility results obtained using microbroth dilution. Bacterial cultures were suspended in Mueller-Hinton broth (BD Biosciences) and adjusted to a 0.5 McFarland standard and inoculated onto the prepared plates using 1 mm pins with a Cathra Replicator (Oxoid, Inc., Ogdensburg, NY, USA). Agar dilution plates were incubated in microaerophilic conditions (5-10% CO 2 ) at 42 C for 24 h. MICs for each isolate was recorded as the lowest antimicrobial concentration for each drug that inhibited growth of each C. jejuni isolate.
Data analysis
Agreement was defined as -1 log 2 dilution between the two tests for each isolate MIC value in order to be consistent with other authors 26, 29 and to account for the amount of error considered inherent in reading the test results. 30 Using the breakpoints defined by NARMS for C. jejuni and general enteric breakpoint for ampicillin (Table 1) , isolates were classified as resistant or susceptible for descriptive purposes. SAS Version 8.2 was used to generate c 2 tests to determine whether there were significant differences in the determination of resistance associated to the testing methodology. The kappa statistic was used to determine the agreement for isolate classification using both agar dilution and microbroth dilution methodology. The kappa, the proportion of agreement between two observers above what would be expected through random chance, was calculated as follows: k ¼ level of agreement observed -level of agreement due to random chance 1 -level of agreement due to random chance , where the level of agreement observed is the proportion of isolates with the same MIC value by both agar dilution and microbroth dilution, and the level of agreement due to random chance is the proportion that would be matched owing to simple random chance.
Results
It should be noted that the isolates chosen for this study do not represent those of all C. jejuni isolated during the longitudinal study. Isolates chosen represented the broadest range of MICs with which to compare agar dilution and microbroth dilution, and were therefore more resistant than the overall susceptibility demonstrated by the C. jejuni isolated from the participating 132 dairy farms enrolled. Also, only isolates from cattle samples that were confirmed to be C. jejuni by PCR were included. Quality control strain of C. jejuni ATCC 33560 was used for each batch of susceptibility testing. In Table 2 , it is demonstrated that the quality control organism performed within the quality control ranges for those antimicrobials for which performance ranges have been established for agar dilution methods. Overall, it is apparent that the quality control organisms performed with similar consistency for both agar dilution and microbroth dilution.
Ampicillin
While exact agreement as determined by the same MIC for each isolate by agar and microbroth dilution was 18.9%, agreement as defined within the -1 dilution error for test interpretation was 82.1% for this antimicrobial (Table 3) . SensiTitre Ò tended to define isolate MICs at one dilution higher when there was disagreement between the two tests, as demonstrated by the difference in MIC 50 , MIC 75 and MIC 90 . The overall level of agreement between the two tests was determined to be good with a k of 0.652. While the overall percentage of isolates determined to be resistant was also higher by the microbroth dilution (6.3 versus 3.2%). This difference was not significant (P = 0.14). 
Ciprofloxacin
Ciprofloxacin is often used to represent the fluoroquinolones drug class when antimicrobial susceptibility or surveillance of foodborne pathogens is being studied. Therefore, it is very encouraging to note the performance of this antimicrobial with both agar dilution and automated microbroth dilution. Exact agreement as determined by the same MIC for each isolate by agar and microbroth dilution was 59.9%, and agreement as defined within the -1 dilution error for test interpretation was 97.1% for ciprofloxacin ( Table 3 ). The measures of dispersement of isolate MIC distributions as defined by MIC 50 and MIC 75 were identical. However, the MIC 90 was determined to be one dilution higher for agar dilution than for microbroth dilution. The overall level of agreement between the two tests was determined to be excellent with a k of 0.886. The overall percentage of isolates determined to be resistant was similar for microbroth dilution (2.9%) as compared with agar dilution (2.3%). This difference was not significant (P = 0.74).
Erythromycin
Erythromycin did not perform as consistently across both techniques. Exact agreement as determined by the same MIC for each isolate by agar and microbroth dilution was 27.9%, and agreement as defined within the -1 dilution error for test interpretation was 79.7% for this antimicrobial (Table 3) . SensiTitre Ò tended to define isolate MICs at one dilution lower when there was disagreement between the two tests. However, this was only evident in the MIC 50 . The other summary measures agreed exactly between the two tests including percentage of resistant isolates, MIC 75 and MIC 90 . The tendency for the microbroth dilution to classify isolates with a lower MIC was reflected in a k of 0.494, which would be considered to be fair to good agreement.
Nalidixic acid
Similar to the fluoroquinolone ciprofloxacin, the nalidixic acid results were similar by both techniques. Exact agreement as determined by the same MIC for each isolate by agar and microbroth dilution was 51.7%, and agreement as defined within the -1 dilution error for test interpretation was 90.1% for nalidixic acid ( Table 3 ). The measures of isolate distributions were the same for agar dilution and microbroth dilution for MIC 50 , MIC 75 and MIC 90 . Individual isolate classification resulted in a good agreement as determined by k of 0.531. While the percentage of resistant isolates, in Table 3 , was higher for microbroth dilution (4.0 versus 2.3%). This was not significantly different (P = 0.35).
Tetracycline
Our dairy isolates demonstrated a broad range of MICs to this antimicrobial. However, in order to obtain isolates with which to test the other drugs, isolates co-resistant to tetracycline were overrepresented in this comparison. Exact agreement for tetracycline as determined by the same MIC for each isolate by agar and microbroth dilution was 41.9%, and agreement as defined within the -1 dilution error for test interpretation was 84.9% for tetracycline ( Table 3 ). The measures of isolate distributions were the same for agar dilution and microbroth dilution for MIC 50 , MIC 75 and MIC 90 . Individual isolate classification resulted good agreement as determined by k of 0.545. While the percentage of resistant isolates, in Table 3 , was higher for microbroth dilution (90.7 versus 88.4%) this was not significantly different (P = 0.48).
Discussion
As noted previously, the aim of this study was not to describe the antimicrobial susceptibility of C. jejuni from dairy sources, so the results should not be considered as representative of the resistance patterns from this source. Isolates were chosen to represent the broadest range of MIC values, and consequently there were more resistant dairy isolates selected for this study. 
Comparison of microbroth dilution to agar dilution
Throughout the literature and across researchers there has been much difficulty in standardizing the laboratory techniques for C. jejuni. This disparity is pervasive at the isolation and identification level, 20 during the determination of appropriate quality control organisms, 32,33 as well as standardizing acceptable antimicrobial testing methods. 26, 29, 34, 35 The lack of standardization for C. jejuni in testing antimicrobial resistance makes it very difficult to discuss trends in susceptibility across research groups and consequently to identify risk factors which may be contributing to those trends globally.
Since NCCLS has validated that C jejuni ATCC 33560 should be used for quality control evaluation of the performance of antimicrobial techniques, it is encouraging that this strain performed with similar consistency for both agar dilution and microbroth dilution. We also demonstrated that C. jejuni 33650 performed within the quality control test ranges with both testing techniques. Overall, our level of agreement between the two techniques of agar dilution and microbroth dilution was good to excellent and varied by the antimicrobial being tested as demonstrated by the kappa values for the descriptive classification of isolates as resistant or susceptible and varied from 0.494 to 0.886. The percentage of concordant results (both tests determined an isolate to be susceptible or resistant) was 96.5% and is reflected in the good to excellent agreement of the kappa values for each antimicrobial.
We also demonstrated that no significant differences were obtained in the classification of descriptive statistics for the isolates being tested. In summarizing the measures of dispersion and central tendency of our isolate collection, we found that agar dilution and microbroth dilution both detected isolates in a similar manner according to percentage of resistant isolates, MIC 50 , MIC 75 and MIC 90 . The most disagreement between agar dilution and microbroth dilution across these measures was by no more than -1 log 2 dilution, which is essentially within the agreement that can be anticipated by the inherent error in reading MICs manually. 30 Agreement defined through MIC outcome values demonstrated that microbroth dilution performed in an acceptable manner to agar dilution testing of our C. jejuni isolates. Exact agreement for MIC outcome ranged from 18.9% for ampicillin to 59.9% for ciprofloxacin. This finding is extremely encouraging for the fluoroquinolone family of antimicrobials, since valid monitoring for the development of decreased susceptibility of C. jejuni to this drug is a concern worldwide. 15, 19 As the definition of agreement within the inherent error of manually reading MIC values has been determined to be -1 log 2 dilution, 30 we demonstrated that microbroth dilution using automated inoculation with a SensiTitre Ò system produced acceptable results. Essential agreement of -1 log 2 dilution ranged from 79.7% for ampicillin to 97.1% agreement for ciprofloxacin. For all of our isolates, the essential agreement was 86.7% (note: weighted for sample size re: ampicillin). Other authors have reported levels of agreement of 78.7% in comparing microbroth dilution with agar dilution, 26 90.0% in comparing microbroth dilution with Etest, 26 66.6% in comparing Etest with agar dilution 36 and 61.9% in comparing Etest with agar dilution. 29 However, these authors tested different antimicrobials, fewer overall isolates and also included Campylobacter coli in their comparison. 26, 29, 36 It should be noted that due to the limited use of antimicrobials in dairy cattle, much lower levels of resistance were observed in our isolates compared with authors studying poultry, swine or human isolates. 13, 16, 24, 25 Therefore, studies conducted using isolates with more exposure to antimicrobial selective pressure and more diverse range of MIC may yield different levels of agreement than we have demonstrated.
In summary, we have demonstrated that microbroth dilution using a SensiTitre Ò autoinoculation system and commercially prepared antimicrobial panels (Trek Diagnostics, Westlake, OH, USA) may be both cost and time efficient while yielding results comparable to agar dilution. For researchers processing a high volume of samples, microbroth dilution may provide an acceptable alternative for testing C. jejuni isolates. Validation of performance of the antimicrobials included for a customized microbroth panel with agar dilution will help ensure comparable results. The opportunity to more efficiently follow trends in C. jejuni may help elucidate trends and risk factors that may be contributing to the reduced susceptibility of this organism to antimicrobials of interest to both human and veterinary medicine. 
